SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

Similar documents
OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS

LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

THIN LAYER CHROMATOGRAPHY

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

E17 ETHYLCELLULOSE. Revision 3 Stage 4

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Title Revision n date

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

EMTRICITABINE AND TENOFOVIR TABLETS

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Heparin Sodium ヘパリンナトリウム

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Lutein Esters from Tagetes Erecta

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Draft proposal for The International Pharmacopoeia

Jagua (Genipin-Glycine) Blue (Tentative)

Guide. homoeopathic preparations. for the elaboration of monographs on

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

CLINDAMYCIN PALMITATE

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

Ergovaline. [Methods listed in the Feed Analysis Standards] 1 Liquid chromatography Note 1, 2 [Feed Analysis Standards, Chapter 5, Section 2

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

SUCROSE OLIGOESTERS TYPE I

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Antioxidant. [Summary of antioxidant]

THERMALLY OXIDIZED SOYA BEAN OIL

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

ISO INTERNATIONAL STANDARD. Animal and vegetable fats and oils Determination of individual and total sterols contents Gas chromatographic method

Unit I (b) Paper Chromatography

TLC SEPARATION OF AMINO ACIDS

Sucrose Esters of Fatty Acids

STANDARD OPERATING PROTOCOL (SOP)

E55A GELATIN, GELLING GRADE Gelatina

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

2 Avilamycin R 1. For chickens (except for broilers) Starting chicks Growing chicks. Starting broilers. Finishing broilers

Flupyradifurone. HPLC Method

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

HPLC Analysis of Sugars

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Phrmacognostical & Pharmaceutical study

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Supporting Information for. Boronic Acid Functionalized Aza-Bodipy (azabdpba) based Fluorescence Optodes for the. analysis of Glucose in Whole Blood

Available online at Universal Research Publications. All rights reserved. Original Article

Analysis of Cannabinoids in Cannabis by UHPLC Using PDA Detection

Final text for addition to The International Pharmacopoeia (June 2010)

Neosolaniol. [Methods listed in the Feed Analysis Standards]

FLUNITRAZEPAM Latest Revision: January 24, 2006

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

EXPERIMENT 13: Isolation and Characterization of Erythrocyte

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.

Most of the ethanol that is used as a biofuel in this country is produced from corn.

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Revision Bulletin 28 Jul Aug 2017 Chemical Medicines Monographs 3

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

The development of a detection method discriminating for

VOLUNTARY MONOGRAPH. Council for Responsible Nutrition March 2006

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

CORESTA RECOMMENDED METHOD NÄ 9

DRAFT TANZANIA STANDARD

Transcription:

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS Simaba cedron ad praeparationes homoeopathicas Other Latin name used in homoeopathy: Simaruba DEFINITION Dried cotyledons of the seed of Simaba cedron Planch. (Quassia cedron Baillon). Content: minimum 0.15 per cent of quassinoids, expressed as santonin (C 15 H 18 O 3 ; M r 46.3) (dried drug). CHARACTERS Macroscopic and microscopic characters described under identification tests A and B. IDENTIFICATION A. Roughly elliptic organs, 3 cm to 5 cm long and 15 mm to 0 mm large. One side is convex the other one is flatter. Yellowish or greyish surface in some places, showing bumps and irregular shapes due to dessiccation. The inside is of a paler yellow. B. Reduce simarouba cedron to a powder (355). The powder is light brown. Examine under a microscope using chloral hydrate solution R. Numerous fragments of cotyledons composed of round to ovoid cells, with cellulose walls; rare wood vessels with spiral patterns. Examine under a microscope using glycerol (50 per cent V/V) R. Numerous starch granules rounded or truncated mostly simple, a few being two to three compounds. C. Thin layer chromatography (..7). Test solution. Add 30 ml of ethanol (65 per cent V/V) R to 3 g of the drug properly divided. Heat under a reflux condenser for 15 min. Allow to cool. Filter. Reference solution. Dissolve 10 mg of rutin R and 10 mg of isoquercitroside R in 30 ml of ethanol (96 per cent) R. Plate: TLC silica gel plate R. Mobile phase: water R, anhydrous formic acid R, ethyle acetate R (10:10:80 V/V/V). Application: 30 µl, as bands. Development: over a path of 10 cm. Drying: in air.

Detection: first spray with a 10 g/l solution of diphenylboric acid aminoethyl ester R in methanol R then with a 50 g/l solution of macrogol 400 R in methanol R. Allow the plate to dry in air for about 30 min. Examine in ultraviolet light at 365 nm. Results: see below the sequence of fluorescent zones present in the chromatograms obtained with the reference solution and the test solution. Furthermore other faint fluorescent zones may be present in the chromatogram obtained with the test solution. Top of the plate Series of blue zones Isoquercitroside : an orange zone An intense blue zone Rutin : an orange zone Reference solution Test solution TESTS Loss on drying (..3): maximum 11.0 per cent, determined on 1.0 g of powdered drug (355), by drying in an oven at 105 C for h. Total ash (.4.15): maximum 3.5 per cent. ASSAY Liquid chromatography (..9). Carry out the test protected from light. Prepare the solutions immediately before use. Test solution. In a 100 ml round-bottomed flask with a ground glass neck, place 0.500 g of powdered drug (355) and 40 ml of ethanol (65 per cent V/V) R. Heat under a reflux condenser on a water-bath for 1 h. Allow to separate. Filter the supernatant on a plug of absorbent cotton. Dilute the residue in 40 ml of ethanol (65 per cent V/V) R, heat again under a reflux condenser on a waterbath for 1 h. Filter, wash the flask and the filter with ethanol (65 per cent V/V) R, then dilute to 100.0 ml with the same solvent. Reference solution. In a 100.0 ml volumetric flask, dissolve 14.0 mg of santonin R in ethanol (65 per cent V/V) R and dilute to 100.0 ml with the same solvent. In a 50.0 ml volumetric flask, place 5.0 ml of this solution and dilute to 50.0 ml with ethanol (65 per cent V/V) R. Column: size: l = 5 cm, Ø = 4.6 mm. stationary phase: octadecylsilyl silica gel for chromatography R (5 µm). temperature: 30 C. Mobile phase: mobile phase A: trifluoroacetic acid (0.05 per cent V/V) R.

3 mobile phase B: acetonitrile R. Flow rate: 1.0 ml/min. Time Mobile phase A Mobile phase B (min) (per cent V/V) (per cent V/V) 0-15 90 70 10 30 15-30 70 15 30 85 30-3 15 0 85 100 3-4 0 100 4-45 0 90 100 10 45-55 90 10 Detection: spectrophotometer at 40 nm. Injection: 0 µl. Elution order: retention time of main quassinoids: about 9 min and 11 min. Retention time of santonin about 4 min. Calculate the percentage content of quassinoids, expressed as santonin, from the expression: A 1 m 10 A m A 1 = total areas of the main two peaks corresponding to quassinoids in the chromatogram obtained with the test solution, A = area of the peak of santonin in the chromatogram obtained with the reference solution, m 1 = mass of the dried drug sample, in grams, m = mass of the sample of santonin in the reference solution, in grams. 1 STOCK DEFINITION Simarouba cedron mother tincture complies with the requirements of the general technique for the preparation of mother tinctures (see Homoeopathic Preparations (1038) and French Pharmacopoeia Authority Supplement). The mother tincture is prepared with ethanol (65 per cent V/V), using dried cotyledons of the seed of Simaba cedron Planch. Content: minimum 0.010 per cent m/m of quassinoids, expressed as santonin (C 15 H 18 O 3 ; M r 46.3). CHARACTERS Appearance: yellow liquid.

4 IDENTIFICATION Thin layer chromatography (..7). Test solution. Mother tincture. Reference solution. Dissolve 10 mg of rutin R and 10 mg of isoquercitroside R in 30 ml of ethanol (96 per cent) R. Plate: TLC silica gel plate R. Mobile phase: water R, anhydrous formic acid R, ethyle acetate R (10:10:80 V/V/V). Application: 30 µl, as bands. Development: over a path of 10 cm. Drying: in air. Detection: first spray with a 10 g/l solution of diphenylboric acid aminoethyl ester R in methanol R then with a 50 g/l solution of macrogol 400 R in methanol R. Allow the plate to dry for about 30 min. Examine in ultraviolet light at 365 nm. Results: see below the sequence of fluorescent zones present in the chromatograms obtained with the reference solution and the test solution. Furthermore other faint fluorescent zones may be present in the chromatogram obtained with the test solution. Top of the plate Series of blue zones Isoquercitroside : an orange zone An intense blue zone Rutin : an orange zone Reference solution Test solution TESTS Ethanol (.9.10): 60 per cent V/V to 70 per cent V/V. Dry residue (.8.16): minimum 0.7 per cent m/m. ASSAY Liquid chromatography (..9). Test solution. In a 5.0 ml volumetric flask, place.000 g of mother tincture and dilute to 5.0 ml with water R. Filter. Reference solution. In a 100.0 ml volumetric flask, dissolve 14.0 mg of santonin R in ethanol (65 per cent V/V) R and dilute to 100.0 ml with the same solvent. In a 50.0 ml volumetric flask, place

5 5.0 ml of this solution and dilute to 50.0 ml with ethanol (65 per cent V/V) R (carry out the test protected from light and inject the solution immediately). Column: size: l = 5 cm, Ø = 4.6 mm. stationary phase: octadecylsilyl silica gel for chromatography R (5 µm). temperature: 30 C. Mobile phase: mobile phase A: trifluoroactic acid (0.05 per cent V/V) R. mobile phase B: acetonitrile R. Flow rate: 1.0 ml/min. Time Mobile phase A Mobile phase B (min) (per cent V/V) (per cent V/V) 0-15 90 70 10 30 15-30 70 15 30 85 30-3 15 0 85 100 3-4 0 100 4-45 0 90 100 10 45-55 90 10 Detection: spectrophotometer at 40 nm. Injection: 0 µl. Elution order: retention time of main quassinoids: about 9 min and 11 min. Retention time of santonin about 4 min. Calculate the percentage content m/m of quassinoids, expressed in santonin, from the expression: A1 m.5 A m A 1 = total areas of the main two peaks corresponding to quassinoids in the chromatogram obtained with the test solution, A = area of the peak of santonin in the chromatogram obtained with the reference solution, m 1 = mass of the mother tincture sample, in grams, m = mass of the sample of santonin in the reference solution, in grams. 1